PSNL stock forecast
Our latest prediction for Personalis, Inc.'s stock price was made on the Oct. 19, 2020 when the stock price was at 27.84$.
In the short term (2weeks), PSNL's stock price should underperform the market by -2.63%. During that period the price should oscillate between -10.81% and +8.61%.
In the medium term (3months), PSNL's stock price should underperform the market by -5.40%. During that period the price should oscillate between -33.70% and +21.90%.Get email alerts
Create a solid portfolio with PSNL
About Personalis, Inc.
Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.
At the moment the company generates 74M USD in revenues.
On its last earning announcement, the company reported a profit of 0.41$ per share.
The book value per share is 3.13$
Three months stock forecastOct. 19, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|